Clinical Trial Update: The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19 [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for MONACO cell therapy study evaluating monocytes as an anti-fibrotic treatment after COVID-19;Phase 1/Phase 2, sponsor Guy's and St Thom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Pulmonary Fibrosis

Drugs mentioned

• MONACO cell therapy (monocyte-based anti-fibrotic therapy)

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: Pulmonary Fibrosis, Interstitial Lung Disease | Phase 1, Phase 2 | Status: UNKNOWN